Publicacions en què col·labora amb Gema Labrador-Herrera (8)

2020

  1. Assessing the impact on intestinal microbiome and clinical outcomes of antibiotherapy optimisation strategies in haematopoietic stem cell transplant recipients: Study protocol for the prospective multicentre OptimBioma study

    BMJ Open, Vol. 10, Núm. 7

  2. Virulence role of the outer membrane protein CarO in carbapenem-resistant Acinetobacter baumannii

    Virulence, Vol. 11, Núm. 1, pp. 1727-1737

2019

  1. Pangenome of acinetobacter baumannii uncovers two groups of genomes, one of them with genes involved in CRISPR/Cas defence systems associated with the absence of plasmids and exclusive genes for biofilm formation

    Microbial Genomics, Vol. 5, Núm. 11

  2. Prevalence and clinical impact of Streptococcus pneumoniae nasopharyngeal carriage in solid organ transplant recipients

    BMC Infectious Diseases, Vol. 19, Núm. 1

2018

  1. Efficacy of colistin and its combination with rifampin in Vitro and in experimental models of infection caused by carbapenemase-producing clinical isolates of Klebsiella pneumoniae

    Frontiers in Microbiology, Vol. 9, Núm. MAY

  2. In vitro Activity of Pentamidine Alone and in Combination With Aminoglycosides, Tigecycline, Rifampicin, and Doripenem Against Clinical Strains of Carbapenemase-Producing and/or Colistin-Resistant Enterobacteriaceae

    Frontiers in Cellular and Infection Microbiology, Vol. 8

2016

  1. Draft genome sequences of seven multidrug-resistant Acinetobacter baumannii strains, isolated from respiratory samples in Spain

    Genome Announcements, Vol. 4, Núm. 2

  2. Efficacy of ceftaroline versus vancomycin in an experimental foreign-body and systemic infection model caused by biofilm-producing methicillin-resistant Staphylococcus epidermidis

    International Journal of Antimicrobial Agents, Vol. 48, Núm. 6, pp. 661-665